AwardedAwarded 2 June 2026
NHS Breast Screening - Support for management of Very High Risk (VHR) Women
NHS England · NHS and health
In brief
NHS England awarded healthcare work to The Christie NHS Foundation Trust on 2 June 2026.
Built from the notice's own fields. Always check the official notice before you bid.
What the notice says
BARD is a confidential database of women in England who have received radiotherapy involving breast tissue before the age of 36. It has been set up to make sure all those at risk can be informed of screening options at the right time.
Current national guidelines recommend that screening should start 8 years after radiotherapy to breast tissue or at age 25 or 30 (depending on circumstances), whichever occurs later.
In addition to making sure that screening appointments arrive at the right time, BARD will allow monitoring of the effectiveness of screening.
There will be a small number of women who have received radiotherapy to breast tissue as part of a treatment plan for diagnoses other than lymphoma. In these instances, the BARD non-lymphoma patient referral form should be completed by a consultant clinical oncologist to refer the patient to BARD. The BARD team then organise breast screening in line with national guidelines.
Who won
| Winner | Value | Dates |
|---|---|---|
| The Christie NHS Foundation Trust | £24,309 | 2 June 2026 to 3 June 2026 |
Values as the award notice gives them, excluding VAT where stated.
Timeline
- Contract details notice · UK7, notice 051808-2026
About the buyer
Similar open tenders
All open healthcare tenders- £7mestimated
- £82kestimated
- Value not stated
- Value not stated
- Value not stated
From notice 051808-2026 on Find a Tender, first published 2 June 2026. We last checked for changes on 28 September 2026.